Literature DB >> 23486449

In chemotherapy for lung cancer, sometimes less is more.

Eric Roeland1, Charles Loprinzi, Timothy J Moynihan, Thomas J Smith, Jennifer Temel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23486449     DOI： 10.6004/jnccn.2013.0034

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  4 in total

1.  FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway.

Authors:  Abedul Haque; Mohammad A Rahman; James R Fuchs; Zhuo Georgia Chen; Fadlo R Khuri; Dong M Shin; A R M Ruhul Amin
Journal:  Cancer Lett       Date:  2015-04-24       Impact factor: 8.679

2.  Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Authors:  Gregory A Masters; Sarah Temin; Christopher G Azzoli; Giuseppe Giaccone; Sherman Baker; Julie R Brahmer; Peter M Ellis; Ajeet Gajra; Nancy Rackear; Joan H Schiller; Thomas J Smith; John R Strawn; David Trent; David H Johnson
Journal:  J Clin Oncol       Date:  2015-08-31       Impact factor: 44.544

3.  Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer.

Authors:  Yuhua Bao; Renee C Maciejewski; Melissa M Garrido; Manish A Shah; Paul K Maciejewski; Holly G Prigerson
Journal:  J Pain Symptom Manage       Date:  2017-12-11       Impact factor: 3.612

4.  The "good planning panel".

Authors:  Thomas J Smith; Joann N Bodurtha
Journal:  Hastings Cent Rep       Date:  2013 Jul-Aug       Impact factor: 2.683
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.